House Vote Has Makers of MCMs Breathing a Little Easier
By Mari Serebrov
Wednesday, January 23, 2013
Stress levels for companies working on medical countermeasures (MCMs) took a welcome nosedive this week as the House overwhelmingly approved a bill to reauthorize the Biomedical Advanced Research and Development Authority (BARDA) and Project BioShield.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.